person

Rannveig S.

Country
Norway
Department
Department of Medicine

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
14
Sites with multiple studies

Has run more than one trial at 14 of 80 partner sites.

Specializations

Nephrology Focus

This investigator specializes in the study and treatment of IgA Nephropathy, a significant kidney condition affecting the glomerular function. Their research encompasses therapeutic approaches for managing this chronic kidney disease.

  • Primary IgA Nephropathy management
  • Proteinuria reduction strategies
  • Renal function preservation

Their work centers on evaluating novel therapeutic agents for treating IgA Nephropathy patients.

Therapeutic Innovation

The investigator focuses on advancing treatment options through the evaluation of novel compounds including iptacopan and povetacicept for kidney disorders. Their work emphasizes long-term safety and efficacy assessments.

  • Novel therapeutic compounds
  • Long-term safety evaluations
  • Treatment tolerability assessment

Their research aims to develop effective therapeutic interventions for chronic kidney conditions.

Clinical Outcomes

The investigator's research emphasizes measuring key clinical outcomes in nephrology, particularly focusing on proteinuria reduction and preservation of kidney function in patients with glomerular diseases.

  • Kidney function monitoring
  • Disease progression assessment
  • Long-term patient outcomes

Their work contributes to understanding the effectiveness of treatments in maintaining renal health.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.